<DOC>
	<DOCNO>NCT01854203</DOCNO>
	<brief_summary>Concurrent cisplatin-based chemotherapy plus radiotherapy increase risk treatment-related death severe acute toxicity . The survival benefit add concurrent chemotherapy intensity modulate radiation patient locoregionally advanced nasopharyngeal carcinoma unclear . Gemcitabine plus cisplatin chemotherapy combine radiotherapy effective well tolerated patient locoregionally advanced NPC .</brief_summary>
	<brief_title>Combination Cisplatin Plus Gemcitabine Induction Chemotherapy Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With Without Concurrent Cisplatin NPC</brief_title>
	<detailed_description>The purpose study compare gemcitabine plus cisplatin induction chemotherapy combine intensity-modulated radiotherapy without concurrent cisplatin patient locoregionally advanced nasopharyngeal carcinoma ( NPC ) , order reevaluate value concurrent cisplatin 4 cycle induction chemotherapy ( gemcitabine+cisplatin ) IMRT use .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients newly histologically confirm nonkeratinizing ( accord World Health Organization ( WHO 2005 ) histologically type ) . A Karnofsky performance status least 80 ; Tumor stag accord 7th American Joint Commission Cancer edition Stage III：T12N2M0 , T3N02M0 Stage IVa：T4N02M0 Stage IVb：Any T、N3 . Adequate marrow : WBC ≥3.5×109 l1 ; platelet count ≥100×109 l1 ; hemoglobin level ≥100 g/l . Normal liver function test : Alanine Aminotransferase ( ALT ) 、Aspartate Aminotransferase ( AST ) &lt; 1.5×upper limit normal ( ULN ) concomitant alkaline phosphatase ( ALP ) ≤2.5×ULN , bilirubin ≤ULN . Adequate renal function : creatinine clearance rate least 60 mL/min . Patients must inform investigational nature study give write informed consent . WHO Type keratinize squamous cell carcinoma . Age &gt; 65 year &lt; 18 year . Distant metastasis , Treatment palliative intent . Pregnancy lactation . history previous radiotherapy nasopharyngeal region previous chemotherapy . history renal disease , unstable cardiac disease require treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Cisplatin</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>intensity-modulated radiation therapy</keyword>
	<keyword>concurrent chemoradiotherapy</keyword>
</DOC>